On November 7, Musk said in an X post that his brain-computer interface company Neuralink is developing a vision chip that may be available in a few years.。

The cause of the matter is a help post from X.。A father on X says his 14-year-old son has CRB1 retinal dystrophy, a rare eye disease。His child is now essentially blind in one eye and meets the legal standard for being blind in the other.。Because the cases were rare, the father decided to go online for help, asking if there were any patients with similar conditions or if a professional who knew how to treat the disease could help。

This post drew Musk's reply。He said Neuralink is working on a vision chip that is expected to be completed in a few years.。He added: "This is our next area of research after enabling phone / computer telepathy for those who have lost their mind-body connection.。We are awaiting regulatory approval for our first human test subject。"

According to the National Eye Institute, about 2.2 million people in the United States are expected to be blind by 2030, when the number of people with poor vision in the United States will be as high as 5 million.。

Once Neuralink's vision chip is developed, it will be a boon to many people with poor eyesight.。The father was also thrilled after seeing Musk's reply, saying he has been keeping a close eye on the company since its inception.。And thanks to Musk for supporting related projects。Not just for the disabled, but for everyone.。"

Neuralink was founded in 2016 and is one of Musk's companies.。The company is best known for its brain-computer interface chips.。

In May, Neuralink's brain-computer interface chip received FDA approval for human clinical trials.。The trial, known as the Precision Robot Implant Brain-Computer Interface (PRIME) study, uses Neauralink's R1 robot to surgically implant a chip into a brain region that controls motor intent.。The N1 implant chip is designed to read the required actions of the test object and convert them into commands from external devices such as computers。

After receiving FDA approval, Neuralink began recruiting patients for its first clinical trials in September.。Those paralyzed by cervical spinal cord injury or amyotrophic lateral sclerosis may be eligible to participate in the study, but the company did not disclose exactly how many participants took part in the trial.。

Neuralink said that after using a robot to surgically implant a brain-computer interface into a participant's brain, the initial goal is expected to be to enable participants to control a computer cursor or keyboard using only their own thoughts.。The trial is expected to take about six years to complete.。

Although Neuralin is more in the market under the halo of its owner Musk, Neuralink is not very leading in its industry。Other brain-computer interface companies, such as Synchron, received FDA approval for human clinical trials as early as August 2020。

Still, in secondary market trading, Neuralink's valuation has been rising for nearly two years, in stark contrast to other startups' shrinking valuations.。

It was reported that in June this year, the company was valued at about $5 billion at the price of private transactions.。Following FDA approval, the sale of Neuralink shares at $55 per share (approximately $7 billion valuation) was even more common in the private market.。

Sim Desai, chief executive of trading platform Hiive, said demand for Neuralink shares had been "huge."。He believes the valuation, based on the value buyers are willing to pay, is around $4.5 billion.。By contrast, Neuralink raised 2 in 2021 at a valuation of about $2 billion..$05 billion。The company's valuation doubled in two years.。

In August this year, Neuralink again won 2.$800 million in external funding, this round of funding was led by the Thiel (Thiel) Founders Fund.。However, the company did not disclose the valuation of the funds raised.。

Although in the non-public trading market, Neuralink has attracted a lot of bulls, but some industry insiders said that Neuralink's commercialization is still a long way off.。Kip Ludwig, a former director of neuroengineering at the National Institutes of Health (NIH), said that even though he was "optimistic" that Neuralink would take at least 10 years to commercialize its brain-computer interface chips.。